SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 3 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $15,622 | -20.5% | 162 | 0.0% | 0.00% | -33.3% |
| Q3 2023 | $19,638 | +5.9% | 162 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $18,552 | -16.9% | 162 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $22,328 | +106223.8% | 162 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $21 | -99.9% | 162 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $18,000 | +50.0% | 162 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $12,000 | -7.7% | 162 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $13,000 | -13.3% | 162 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $15,000 | 0.0% | 162 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | +25.0% | 162 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $12,000 | -57.1% | 162 | 0.0% | 0.00% | -60.0% |
| Q4 2020 | $28,000 | +21.7% | 162 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $23,000 | -11.5% | 162 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $26,000 | +62.5% | 162 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $16,000 | – | 162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |